Randomized trial reveals combination of pregabalin and lacosamide improves pain outcomes in diabetic neuropathy, suggesting enhanced management approaches.
Key Points
Combination therapy of pregabalin and lacosamide significantly reduces pain in diabetic neuropathy patients compared to pregabalin alone.
Post-treatment visual analog scale scores indicate Group A had a mean score of 3.07 and Group B achieved better at 2.30, both showing statistical significance.
Efficacy rates of treatment were 58.2% for pregabalin monotherapy and 80.6% for the combination therapy, pointing to the benefit of adjunctive lacosamide.
The study supports using lacosamide with pregabalin in treating diabetic neuropathy, warranting further investigation of this approach.